AI
MED icon

Analytic Investors’s Medifast MED Stock Holding History

Analytic Investors’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$437K Buy
+11,554
New +$414K ﹤0.01% 493

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Analytic Investors's MED Position: Q3 2016 in Review

Analytic Investors opened a new position in Medifast (MED) in Q3 2016: 11,554 shares worth $437K. The stake represents ﹤0.01% of the portfolio and ranks #493 among its holdings.

165 funds tracked by Wall St. Rank hold MED as of Q3 2016.

  • Analytic Investors held 11,554 shares of Medifast worth $437K as of Q3 2016.
  • Medifast was a new Analytic Investors position in Q3 2016.
  • Medifast made up ﹤0.01% of Analytic Investors's portfolio in Q3 2016, its #493 holding.
  • 165 funds tracked by Wall St. Rank held Medifast as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.